Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01417299

The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements

Status
Withdrawn
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators are studying the impact of RPh201 on chronic vegetative patients. RPh201 has been reported to induce neuronal regeneration in animal models. Evaluation will be done by combining clinical /behavioral assessment with fMRI studies.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRPh201Patients will receive 400 microliter s.c., of RPh201 twice a week for 3 months
DIETARY_SUPPLEMENTsalinePatients will receive 400 microliter s.c., of saline twice a week for 3 months

Timeline

Start date
2011-10-01
Primary completion
2017-10-01
Completion
2018-10-01
First posted
2011-08-16
Last updated
2015-09-22

Source: ClinicalTrials.gov record NCT01417299. Inclusion in this directory is not an endorsement.